Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Determinants and Outcomes of Cerebrovascular Disease in Patients with COVID-19 in the Philippines: An Analysis of 10881 Cases
Cerebrovascular Disease and Interventional Neurology
S6 - Cerebrovascular Disease: Diagnosis, Prediction, and Population Health (4:54 PM-5:06 PM)
008

While most large studies about the possible association of COVID 19 and stroke were done in rich countries, only few small studies have been done in low to mid income countries like the Philippines.

To determine the risk factors of stroke among COVID 19 patients and analyze if there is an association between these factors and the incidence of stroke, and between mortality and stroke, in this cohort.

This is an observational study done in 37 referral hospitals for COVID-19 all over the country. RT-PCR confirmed adult COVID-19 patients more than 18 years of age were included in the study. For those who consented, a pre-made detailed abstraction form containing the variables of interest is filled up by the field neurologist by clinical observation, chart review and interview of the relatives or the patient.

The incidence of stroke among COVID-19 patients was 3.4% (n=367). More died among patients with stroke than those without (42.2% vs 14.7%, p<0.01). In addition, more patients were admitted in the ICU (43.3% vs 15.0%, p<0.01) regardless of causes in the same cohort. Smoking (95% CI: 0.27 to 0.53, p<0.0001), hypertension (95% CI:0.43 to 0.68, p<0.0001), presence of heart failure (95% CI: 0.07 to 0.62, p=0.01), presence of any past neurologic co-morbidities (95% CI:0.34 to 0.10, p=0.004) and past history of stroke (95% CI:0.60 to 1.09, p<0.0001) had positive while being a health care worker (95% CI: -1.12 to -0.35, p<0.0004) had negative significant associations with stroke.

COVID 19 stroke patients in LMIC have higher mortality and ICU admission rates than patients with COVID 19 alone or COVID 19 stroke patients from developed countries.

Authors/Disclosures

PRESENTER
No disclosure on file
Roland Dominic Jamora (Philippine General Hospital) Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Marie Charmaine Sy (University of the Philippines Manila-Philippine General Hospital) Marie Charmaine Sy has nothing to disclose.
Michelle Anlacan Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as a Consultant for Torrent Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medichem Philippines. Michelle Anlacan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hi Eisai Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natrapharm Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's disease association of the philippines. Michelle Anlacan has received research support from Philippine Council for Health Research and Development. Michelle Anlacan has received research support from Philippine Neurological Association.
Adrian Espiritu (Ontario Shores Centre for Mental Health Sciences) Dr. Espiritu has nothing to disclose.